ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients

David J. Hermel, Samantha R. Spierling Bagsic, Carrie L. Costantini, James R. Mason, Zhubin J. Gahvari, Alan Saven

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

This study investigates the association between ABO blood phenotype and COVID-19 severity, measured by intensive care unit admission, need for intubation, hospitalization length and death. It further explores clinical predictors of COVID-19 severity within a primarily Hispanic demographic in San Diego County. Materials & methods: We retrospectively reviewed 942 total patients, 473 with available blood type, hospitalized at five Scripps Health hospitals with COVID-19. Results: No significant association was found between ABO phenotype and COVID-19 severity on multivariate analysis, while a diagnosis of anemia and male sex was associated with all severity outcomes on exploratory analysis. Conclusion: Our results provide relevant clinical correlates of COVID-19 severity and help better elucidate the association between ABO phenotype and COVID-19.

Original languageEnglish (US)
Article number0045
JournalFuture Science OA
Volume7
Issue number8
DOIs
StatePublished - 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021 The authors.

Keywords

  • ABO blood type
  • COVID-19
  • Hispanic
  • San Diego
  • anemia
  • male

Fingerprint

Dive into the research topics of 'ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients'. Together they form a unique fingerprint.

Cite this